## JAMUNARANI VEERARAGHAVAN

| | Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| One Baylor Plaza  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=HKo99GvGMor7T8Hb5X7QK6aNIBmLgSQMMB4vPC7RBnU%3d&rnd=cf8942c7-6a63-46aa-a2a9-7c1d3c9e4452)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=3010617)  
  
![](https://profiles.viictr.org/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx?NodeID=3010617&cachekey=772357c1-3c40-41d5-891c-28cd3d739a95)  
  

Other Positions| Title| Assistant Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Breast Center  
Division| Breast Cancer Center  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. **Veeraraghavan J** , [Gutierrez C](https://profiles.viictr.org/profile/265496), De Angelis C, Davis R, Wang T, Pascual T, Selenica P, Sanchez K, Nitta H, Kapadia M, Pavlick AC, Galvan P, Rexer B, Forero-Torres A, Nanda R, Storniolo AM, Krop IE, Goetz MP, [Nangia JR](https://profiles.viictr.org/profile/266130), Wolff AC, Weigelt B, Reis-Filho JS, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Prat A, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128), [Rimawi MF](https://profiles.viictr.org/profile/269416). A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer. Clin Cancer Res. 2023 08 15; 29(16):3101-3109. PMID: [37195235](//www.ncbi.nlm.nih.gov/pubmed/37195235); PMCID: [PMC10923553](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10923553).

Citations:
[2](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37195235/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  2. Fu X, Pereira R, [Liu CC](https://profiles.viictr.org/profile/31721876), De Angelis C, Shea MJ, Nanda S, Qin L, Mitchell T, Cataldo ML, **Veeraraghavan J** , Sethunath V, Giuliano M, [Gutierrez C](https://profiles.viictr.org/profile/265496), Gyorffy B, Trivedi MV, Cohen O, Wagle N, Nardone A, Jeselsohn R, [Rimawi MF](https://profiles.viictr.org/profile/269416), Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer. Cell Rep. 2023 Aug 29; 42(8):112821. PMID: [37467106](//www.ncbi.nlm.nih.gov/pubmed/37467106).

Citations:  Fields:

Cel Cell BiologyMol Molecular Biology

  3. De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, **Veeraraghavan J** , Nanda S, Qin L, Sethunath V, Wang T, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, [Rimawi MF](https://profiles.viictr.org/profile/269416), Jansen VM, Jeselsohn R, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). Correction: Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clin Cancer Res. 2021 Sep 01; 27(17):4939. PMID: [34470810](//www.ncbi.nlm.nih.gov/pubmed/34470810).

Citations:  Fields:

Neo Neoplasms

  4. **Veeraraghavan J** , [Gutierrez C](https://profiles.viictr.org/profile/265496), Sethunath V, Mehravaran S, Giuliano M, Shea MJ, Mitchell T, Wang T, Nanda S, Pereira R, Davis R, Goutsouliak K, Qin L, De Angelis C, Diala I, Lalani AS, [Nagi C](https://profiles.viictr.org/profile/6998780), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Rimawi MF](https://profiles.viictr.org/profile/269416), Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models. NPJ Breast Cancer. 2021 May 27; 7(1):63. PMID: [34045483](//www.ncbi.nlm.nih.gov/pubmed/34045483); PMCID: [PMC8159999](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8159999).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34045483/citedby/)

  5. Wang X, **Veeraraghavan J** , Liu CC, Cao X, Qin L, Kim JA, Tan Y, Loo SK, Hu Y, Lin L, Lee S, Shea MJ, Mitchell T, Li S, Ellis MJ, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Schiff R](https://profiles.viictr.org/profile/269128), Wang XS. Therapeutic Targeting of Nemo-like Kinase in Primary and Acquired Endocrine-resistant Breast Cancer. Clin Cancer Res. 2021 05 01; 27(9):2648-2662. PMID: [33542078](//www.ncbi.nlm.nih.gov/pubmed/33542078); PMCID: [PMC8653766](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8653766).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33542078/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  6. De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, **Veeraraghavan J** , Nanda S, Qin L, Sethunath V, Wang T, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, [Rimawi MF](https://profiles.viictr.org/profile/269416), Jansen VM, Jeselsohn R, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer. Clin Cancer Res. 2021 09 01; 27(17):4870-4882. PMID: [33536276](//www.ncbi.nlm.nih.gov/pubmed/33536276); PMCID: [PMC8628647](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8628647).

Citations:
[11](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33536276/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  7. Liu CC, **Veeraraghavan J** , Tan Y, Kim JA, Wang X, Loo SK, Lee S, Hu Y, Wang XS. A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers. Clin Cancer Res. 2021 02 01; 27(3):785-798. PMID: [33172895](//www.ncbi.nlm.nih.gov/pubmed/33172895); PMCID: [PMC7934498](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7934498).

Citations:
[4](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33172895/citedby/) Fields:

Neo Neoplasms

Translation:HumansCells

  8. Li L, Lin L, **Veeraraghavan J** , Hu Y, Wang X, Lee S, Tan Y, [Schiff R](https://profiles.viictr.org/profile/269128), Wang XS. Therapeutic role of recurrent ESR1-CCDC170 gene fusions in breast cancer endocrine resistance. Breast Cancer Res. 2020 08 08; 22(1):84. PMID: [32771039](//www.ncbi.nlm.nih.gov/pubmed/32771039); PMCID: [PMC7414578](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7414578).

Citations:
[5](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32771039/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  9. Schettini F, Conte B, Rognoni C, Griguolo G, Guarneri V, Conte PF, Locci M, Brase JC, Gonzalez-Farre B, Villagrasa P, De Placido S, [Schiff R](https://profiles.viictr.org/profile/269128), **Veeraraghavan J** , [Rimawi MF](https://profiles.viictr.org/profile/269416), Osborne CK, Perou CM, Carey LA, Pascual T, Chic N, Bras?-Maristany F, Galv?n P, Mart?nez O, Adamo B, Vidal M, Mu?oz M, Fern?ndez-Martinez A, Pernas S, Prat A. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis. Cancer Treat Rev. 2020 Mar; 84:101965. PMID: [32000054](//www.ncbi.nlm.nih.gov/pubmed/32000054); PMCID: [PMC7230134](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7230134).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32000054/citedby/) Fields:

Ant Antineoplastic AgentsNeo Neoplasms

Translation:Humans

  10. De Angelis C, [Gutierrez C](https://profiles.viictr.org/profile/265496), Llombart-Cussac A, Wang T, Rexer B, Forero A, Wolff AC, **Veeraraghavan J** , Krop I, Pavlick AC, Izquierdo M, Rodrik-Outmezguine V, Reis-Filho JS, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Oliveira M, Dieci MV, Griguolo G, Fasani R, Nuciforo P, Parker JS, Conte P, [Schiff R](https://profiles.viictr.org/profile/269128), Guarneri V, Osborne CK, [Rimawi MF](https://profiles.viictr.org/profile/269416), Prat A, Pascual T, Cort?s J, Par? L, Morales S, Adamo B, Bras?-Maristany F, Vidal M, Galv?n P, Bermejo B. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade. J Natl Cancer Inst. 2020 01 01; 112(1):46-54. PMID: [31037288](//www.ncbi.nlm.nih.gov/pubmed/31037288); PMCID: [PMC7850037](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7850037).

Citations:
[38](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31037288/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  11. Goutsouliak K, **Veeraraghavan J** , Sethunath V, De Angelis C, Osborne CK, [Rimawi MF](https://profiles.viictr.org/profile/269416), [Schiff R](https://profiles.viictr.org/profile/269128). Towards personalized treatment for early stage HER2-positive breast cancer. Nat Rev Clin Oncol. 2020 04; 17(4):233-250. PMID: [31836877](//www.ncbi.nlm.nih.gov/pubmed/31836877); PMCID: [PMC8023395](//www.ncbi.nlm.nih.gov/pmc/articles/PMC8023395).

Citations:
[51](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31836877/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  12. Fu X, Pereira R, De Angelis C, **Veeraraghavan J** , Nanda S, Qin L, Cataldo ML, Sethunath V, Mehravaran S, [Gutierrez C](https://profiles.viictr.org/profile/265496), Chamness GC, [Feng Q](https://profiles.viictr.org/profile/267850), [O'Malley BW](https://profiles.viictr.org/profile/269511), Selenica P, Weigelt B, Reis-Filho JS, Cohen O, Wagle N, Nardone A, Jeselsohn R, Brown M, [Rimawi MF](https://profiles.viictr.org/profile/269416), Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer. Proc Natl Acad Sci U S A. 2019 Dec 26; 116(52):26823-26834. PMID: [31826955](//www.ncbi.nlm.nih.gov/pubmed/31826955); PMCID: [PMC6936436](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6936436).

Citations:
[34](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31826955/citedby/) Fields:

Sci Science

  13. [Rimawi MF](https://profiles.viictr.org/profile/269416), Niravath P, Wang T, Rexer BN, Forero A, Wolff AC, Nanda R, Storniolo AM, Krop I, Goetz MP, [Nangia JR](https://profiles.viictr.org/profile/266130), Jiralerspong S, Pavlick A, **Veeraraghavan J** , De Angelis C, [Gutierrez C](https://profiles.viictr.org/profile/265496), [Schiff R](https://profiles.viictr.org/profile/269128), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Osborne CK, Translational Breast Cancer Research Consortium. TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer. Clin Cancer Res. 2020 02 15; 26(4):821-827. PMID: [31662331](//www.ncbi.nlm.nih.gov/pubmed/31662331).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31662331/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  14. De Angelis C, [Nagi C](https://profiles.viictr.org/profile/6998780), Hoyt CC, Liu L, Roman K, Wang C, Zheng Y, **Veeraraghavan J** , Sethunath V, Nuciforo P, Wang T, Tsimelzon A, Mao S, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Trivedi MV](https://profiles.viictr.org/profile/270103), Cataldo ML, Pavlick A, Wolff AC, Weigelt B, Reis-Filho JS, Prat A, [Gutierrez C](https://profiles.viictr.org/profile/265496), Osborne CK, [Rimawi MF](https://profiles.viictr.org/profile/269416), [Schiff R](https://profiles.viictr.org/profile/269128). Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy. Clin Cancer Res. 2020 02 01; 26(3):738-745. PMID: [31653641](//www.ncbi.nlm.nih.gov/pubmed/31653641); PMCID: [PMC7002194](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7002194).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31653641/citedby/) Fields:

Neo Neoplasms

Translation:HumansCellsCTClinical Trials

  15. Sethunath V, Hu H, De Angelis C, **Veeraraghavan J** , Qin L, Wang N, Wang T, Fu X, Nardone A, Pereira R, Nanda S, Griffith OL, Tsimelzon A, [Shaw C](https://profiles.viictr.org/profile/269433), Chamness GC, Reis-Filho JS, Weigelt B, Heiser LM, [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Huang S](https://profiles.viictr.org/profile/267743), [Rimawi MF](https://profiles.viictr.org/profile/269416), Gray JW, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128), Simon LM. Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer. Mol Cancer Res. 2019 11; 17(11):2318-2330. PMID: [31420371](//www.ncbi.nlm.nih.gov/pubmed/31420371); PMCID: [PMC6825570](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6825570).

Citations:
[19](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31420371/citedby/) Fields:

Cel Cell BiologyMol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  16. Nardone A, Weir H, Delpuech O, Brown H, De Angelis C, Cataldo ML, Fu X, Shea MJ, Mitchell T, **Veeraraghavan J** , [Nagi C](https://profiles.viictr.org/profile/6998780), Pilling M, [Rimawi MF](https://profiles.viictr.org/profile/269416), [Trivedi M](https://profiles.viictr.org/profile/270103), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), Chamness GC, Jeselsohn R, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. Br J Cancer. 2019 02; 120(3):331-339. PMID: [30555156](//www.ncbi.nlm.nih.gov/pubmed/30555156); PMCID: [PMC6353941](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6353941).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30555156/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  17. **Veeraraghavan J** , De Angelis C, Reis-Filho JS, Prat A, [Rimawi MF](https://profiles.viictr.org/profile/269416), Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128), Pascual T. De-escalation of treatment in HER2-positive breast cancer: Determinants of response and mechanisms of resistance. Breast. 2017 Aug; 34 Suppl 1:S19-S26. PMID: [28687441](//www.ncbi.nlm.nih.gov/pubmed/28687441); PMCID: [PMC6050048](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6050048).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28687441/citedby/) Fields:

End EndocrinologyNeo Neoplasms

Translation:HumansCells

  18. Xu X, De Angelis C, Burke KA, Nardone A, Hu H, Qin L, **Veeraraghavan J** , Sethunath V, Heiser LM, Wang N, Ng CKY, Chen ES, Renwick A, Wang T, Nanda S, Shea M, Mitchell T, Rajendran M, Waters I, Zabransky DJ, Scott KL, [Gutierrez C](https://profiles.viictr.org/profile/265496), [Nagi C](https://profiles.viictr.org/profile/6998780), Geyer FC, Chamness GC, Park BH, [Shaw CA](https://profiles.viictr.org/profile/269433), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Rimawi MF](https://profiles.viictr.org/profile/269416), Gray JW, Weigelt B, Reis-Filho JS, Osborne CK, [Schiff R](https://profiles.viictr.org/profile/269128). HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer. Clin Cancer Res. 2017 Sep 01; 23(17):5123-5134. PMID: [28487443](//www.ncbi.nlm.nih.gov/pubmed/28487443); PMCID: [PMC5762201](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5762201).

Citations:
[39](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28487443/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  19. Kim JA, Tan Y, Wang X, Cao X, **Veeraraghavan J** , Liang Y, Edwards DP, [Huang S](https://profiles.viictr.org/profile/267743), Pan X, Li K, [Schiff R](https://profiles.viictr.org/profile/269128), Wang XS. Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers. Nat Commun. 2016 10 03; 7:12991. PMID: [27694828](//www.ncbi.nlm.nih.gov/pubmed/27694828); PMCID: [PMC5064015](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5064015).

Citations:
[21](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27694828/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  20. Kim JA, [Anurag M](https://profiles.viictr.org/profile/15619466), **Veeraraghavan J** , [Schiff R](https://profiles.viictr.org/profile/269128), Li K, Wang XS. Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M Checkpoint. Mol Cancer Res. 2016 10; 14(10):920-927. PMID: [27489360](//www.ncbi.nlm.nih.gov/pubmed/27489360); PMCID: [PMC5065758](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5065758).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27489360/citedby/) Fields:

Cel Cell BiologyMol Molecular BiologyNeo Neoplasms

Translation:HumansCells

  21. **Veeraraghavan J** , Ma J, Hu Y, Wang XS. Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications. Breast Cancer Res Treat. 2016 07; 158(2):219-32. PMID: [27372070](//www.ncbi.nlm.nih.gov/pubmed/27372070); PMCID: [PMC4979600](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4979600).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27372070/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  22. **Veeraraghavan J** , Tan Y, Cao XX, Kim JA, Wang X, Chamness GC, Maiti SN, Cooper LJ, Edwards DP, [Contreras A](https://profiles.viictr.org/profile/12582874), [Hilsenbeck SG](https://profiles.viictr.org/profile/268374), [Chang EC](https://profiles.viictr.org/profile/267726), [Schiff R](https://profiles.viictr.org/profile/269128), Wang XS. Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of oestrogen receptor-positive breast cancers. Nat Commun. 2014 Aug 07; 5:4577. PMID: [25099679](//www.ncbi.nlm.nih.gov/pubmed/25099679); PMCID: [PMC4130357](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4130357).

Citations:
[70](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25099679/citedby/) Fields:

Bio BiologySci Science

Translation:HumansAnimalsCells

  23. Aravindan N, Thomas CR, Aravindan S, Mohan AS, **Veeraraghavan J** , Natarajan M. Irreversible EGFR inhibitor EKB-569 targets low-LET ?-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma. PLoS One. 2011; 6(12):e29705. PMID: [22242139](//www.ncbi.nlm.nih.gov/pubmed/22242139); PMCID: [PMC3248439](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3248439).

Citations:
[9](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22242139/citedby/) Fields:

Med Medicine (General)Sci Science

Translation:HumansCells

  24. **Veeraraghavan J** , Natarajan M, Lagisetty P, Awasthi V, Herman TS, Aravindan N. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas. 2011 Oct; 40(7):1107-19. PMID: [21697760](//www.ncbi.nlm.nih.gov/pubmed/21697760).

Citations:
[25](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21697760/citedby/) Fields:

Gas Gastroenterology

Translation:HumansAnimalsCells

  25. **Veeraraghavan J** , Natarajan M, Aravindan S, Herman TS, Aravindan N. Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cells. J Biol Chem. 2011 Jun 17; 286(24):21588-600. PMID: [21527635](//www.ncbi.nlm.nih.gov/pubmed/21527635); PMCID: [PMC3122217](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3122217).

Citations:
[35](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21527635/citedby/) Fields:

Bio Biochemistry

Translation:HumansAnimalsCells

  26. Aravindan N, **Veeraraghavan J** , Madhusoodhanan R, Herman TS, Natarajan M. Curcumin regulates low-linear energy transfer ?-radiation-induced NF?B-dependent telomerase activity in human neuroblastoma cells. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1206-15. PMID: [21236599](//www.ncbi.nlm.nih.gov/pubmed/21236599); PMCID: [PMC3071590](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3071590).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21236599/citedby/) Fields:

Neo NeoplasmsRad RadiologyRad Radiotherapy

Translation:HumansCells

  27. **Veeraraghavan J** , Aravindan S, Natarajan M, Awasthi V, Herman TS, Aravindan N. Neem leaf extract induces radiosensitization in human neuroblastoma xenograft through modulation of apoptotic pathway. Anticancer Res. 2011 Jan; 31(1):161-70. PMID: [21273594](//www.ncbi.nlm.nih.gov/pubmed/21273594).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21273594/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  28. **Veeraraghavan J** , Natarajan M, Herman TS, Aravindan N. Low-dose ?-radiation-induced oxidative stress response in mouse brain and gut: regulation by NF?B-MnSOD cross-signaling. Mutat Res. 2011 Jan 10; 718(1-2):44-55. PMID: [21056117](//www.ncbi.nlm.nih.gov/pubmed/21056117).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21056117/citedby/) Fields:

Gen Genetics

Translation:AnimalsCells

  29. Madhusoodhanan R, Natarajan M, **Veeraraghavan J** , Herman TS, Jamgade A, Singh N, Aravindan N. NFkappaB signaling related molecular alterations in human neuroblastoma cells after fractionated irradiation. J Radiat Res. 2009 Jul; 50(4):311-24. PMID: [19436149](//www.ncbi.nlm.nih.gov/pubmed/19436149).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19436149/citedby/) Fields:

Env Environmental HealthNeo NeoplasmsRad Radiology

Translation:HumansCells

  30. Madhusoodhanan R, Natarajan M, **Veeraraghavan J** , Herman TS, Aravindan N. NFkappaB activity and transcriptional responses in human breast adenocarcinoma cells after single and fractionated irradiation. Cancer Biol Ther. 2009 May; 8(9):765-73. PMID: [19276662](//www.ncbi.nlm.nih.gov/pubmed/19276662).

Citations:
[14](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19276662/citedby/) Fields:

Neo NeoplasmsThe Therapeutics

Translation:HumansCells

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 30 publications over 11 distinct years, with a maximum of
5 publications in 2011 and
2019](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|5&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,40,20,100,0,0,20,0,60,40,20,100,80,80,0,40,0&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2009| 2  
2010| 1  
2011| 5  
2014| 1  
2016| 3  
2017| 2  
2018| 1  
2019| 5  
2020| 4  
2021| 4  
2023| 2  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

VEERARAGHAVAN's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (172)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Receptor, ErbB-2](https://profiles.viictr.org/profile/250511)
  * [Breast Neoplasms](https://profiles.viictr.org/profile/256408)
  * [Azadirachta](https://profiles.viictr.org/profile/248961)
  * [Radiation-Sensitizing Agents](https://profiles.viictr.org/profile/255061)
  * [Plant Extracts](https://profiles.viictr.org/profile/248247)

[Explore](https://profiles.viictr.org/profile/3010617/198)

_

Co-Authors (15)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [SCHIFF, RACHEL](https://profiles.viictr.org/profile/269128)
  * [RIMAWI, MOTHAFFAR](https://profiles.viictr.org/profile/269416)
  * [HILSENBECK, SUSAN](https://profiles.viictr.org/profile/268374)
  * [GUTIERREZ, CAROLINA](https://profiles.viictr.org/profile/265496)
  * [NAGI, CHANDANDEEP](https://profiles.viictr.org/profile/6998780)

[Explore](https://profiles.viictr.org/profile/3010617/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [HUNG, MIEN-CHIE](https://profiles.viictr.org/profile/12582486)
  * [MERIC-BERNSTAM, FUNDA](https://profiles.viictr.org/profile/12583329)
  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [MILLS, GORDON B](https://profiles.viictr.org/profile/12582930)
  * [UENO, NAOTO T](https://profiles.viictr.org/profile/12582890)

[Explore](https://profiles.viictr.org/profile/3010617/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [KOSTELYNA, STEFAN](https://profiles.viictr.org/profile/51399053)
  * [LEZAMA, MAYBELLINE](https://profiles.viictr.org/profile/37888853)
  * [MURREY-ITTMANN, JACKSON](https://profiles.viictr.org/profile/29494196)
  * [NALAM, ROOPA](https://profiles.viictr.org/profile/15317721)
  * [YOON, ALYSSA](https://profiles.viictr.org/profile/38304507)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [BOWERS, EVE](https://profiles.viictr.org/profile/265778)
  * [DONOHUE, WILLIAM](https://profiles.viictr.org/profile/266739)
  * [EICHHORN, RALPH](https://profiles.viictr.org/profile/267707)
  * [KATHURIA, NAVNEET](https://profiles.viictr.org/profile/266151)
  * [SIDDIQUI, IMRAN](https://profiles.viictr.org/profile/266463)

_

